Adare’s scientific teams boast unprecedented experience in the development of oral solid dosage forms
Our formulation experts partner with you to provide innovative solutions to complex dosage form challenges.
- Dedicated GMP Development Laboratory
- Additional Non-GMP Small Scale Laboratory
- Provides additional early-stage non-GMP development capacity
- Produce smaller batches using less active pharmaceutical ingredients (APIs).
- Mirrors Adare’s pilot and production capabilities
- Start projects immediately
- Faster development timelines
- Integrated R&D validated through to commercial manufacturing
- Full-service capabilities for even the most complex product creation
- In-house regulatory affairs team with a proven global track record
- Flexible Business Model customized to fit your program
Speak With An Expert
Nathan Dormer
Director, Drug Product Development
Nathan Dormer, Ph.D., is the Director of Drug Product Development at Adare Pharma Solutions and is responsible for pharmaceutical development activities at Adare’s Lenexa, KS and Philadelphia, PA facilities, where he supports a team of formulation scientists and analysts. He is a pharmaceutical scientist and bioengineer by training, with more than 16 years of experience developing microsphere-based solid oral and parenteral/implantable dosage forms in academic, innovator, and CDMO settings. Dr. Dormer earned his B.S. in Chemical Engineering and his Ph.D. (w/Honors) in Bioengineering from The University of Kansas while receiving NIH-sponsored Pharmaceutical Biotech Training.